Drawing for INFANDX HYPOXE-TEST

USPTO serial 79234733

INFANDX HYPOXE-TEST

Reviewed by CopyMark Law Group

Reg. 5736328Status 709
Filing date
Status date
Registration date
Apr 30, 2019
Examiner
WIENER, MICHAEL
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with INFANDX HYPOXE-TEST?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

George A. Metzenthin

George A. Metzenthin Cahn & Samuels, LLP1100 17th St., NW, Ste. 401Washington, DC 20036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic reagents; diagnostic kits consisting of medical diagnostic reagents for detecting metabolites for use in diagnosis of asphyxia, hypoxic-ischemic encephalopathy, or brain injury; all of the aforementioned goods in this class onlySECTION 71 - CANCELLED—
009Scientific apparatus, instruments and devices, namely, photometers, fluorometers, flow meters, apparatus and instruments for electrophoresis and mass spectrometry, liquid chromatography instruments, gas chromatography instruments, plasmone resonance spectrometers, and electrodes for research and examination purposes, and laboratory consumables for the above mentioned apparatus, instruments and devices, namely, laboratory filters, pipetting tips, and optical filters; all of the aforementioned goods in this class onlySECTION 71 - CANCELLED—
010Medical and veterinary equipment, apparatus and instruments for treating asphyxia, hypoxic-ischemic encephalopathy, or brain injury; analytical equipment for the analysis of body fluids; diagnostic equipment for medical purposes in diagnosing asphyxia, hypoxic-ischemic encephalopathy, or brain injury; all of the aforementioned goods in this class onlySECTION 71 - CANCELLED—
016Printed matter, namely, books, brochures and texts, all in the field of neonatal care, asphyxia, and multilevel multivariate biomarkers; printed educational materials in the field of neonatal care, asphyxia, and multilevel multivariate biomarkers; teaching materials in the field of neonatal care, asphyxia, and multilevel multivariate biomarkers; all of the aforementioned goods in this class onlySECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 14, 2026INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Nov 14, 2025C71TCANCELLED SECTION 71—
May 19, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 30, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Sep 13, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 22, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 22, 2019FIMPFINAL DISPOSITION PROCESSED—
Jul 30, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 30, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 12, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 8, 2019GPNXNOTIFICATION PROCESSED BY IB—
Jan 23, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 23, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 23, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 23, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 23, 2019NPUBNOTICE OF PUBLICATION—
Jan 4, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 3, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 2, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 2, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 7, 2018RFNTREFUSAL PROCESSED BY IB—
Jul 17, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 17, 2018RFRRREFUSAL PROCESSED BY MPU—
Jul 6, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 5, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 26, 2018DOCKASSIGNED TO EXAMINER—
Jun 26, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 22, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 21, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance